Skip to main content
SpringerLink
Log in

Increased serum levels of ischemia-modified albumin and C-reactive protein in type 1 diabetes patients with ketoacidosis

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Ischemia-modified albumin (IMA) levels have been advocated as a biomarker for evaluating the oxidative stress status. No data are showed on the potential role of IMA in type 1 diabetes (T1D). We aimed to establish the correlation among serum levels of IMA, C-reactive protein (CRP), and diabetic ketoacidosis (DKA) in patients with T1D. Fifty-seven patients with T1D, 27 patients with DKA, and 40 controls were enrolled. Serum IMA and CRP levels were measured and evaluated to distinguish from DKA. CRP and IMA levels were significantly elevated in patients with DKA at admission to the hospital compared to non-DKA and control subjects. CRP and IMA levels were higher in non-DKA patients than in controls. CRP, plasma glucose, and IMA levels were reduced after insulin treatment. Serum IMA levels were an independent risk marker for DKA (OR = 1.225, p = 0.002, 95 % CI: 1.076–1.394). Receiver operating characteristic curve analyses showed no difference in the areas under curve for serum IMA and CRP values. This study indicates that IMA and CRP levels were significantly correlated with DKA diagnosis. IMA can act as a biomarker that reflects the presence of DKA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. A. Gunduz, S. Turedi, A. Mentese, V. Altunayoglu, I. Turan, S.C. Karahan, M. Topbas, M. Aydin, I. Eraydin, B. Akcan, Ischemia-modified albumin levels in cerebrovascular accidents. Am. J. Emerg. Med. 26, 874–878 (2008)

    Article  PubMed  Google Scholar 

  2. S.G. Ma, W. Xu, C.L. Wei, X.J. Wu, B. Hong, Z.J. Wang, H.R. Hao, H.Q. Guo, Role of ischemia-modified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients. Clin. Biochem. 44, 1299–1303 (2011)

    Article  PubMed  CAS  Google Scholar 

  3. S. Turedi, O. Cinar, I. Yavuz, A. Mentese, A. Gunduz, S.C. Karahan, M. Topbas, E. Cevik, A.O. Yildirim, A. Uzun, U. Kaldirim, Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population. J. Nephrol. 23, 335–340 (2010)

    PubMed  Google Scholar 

  4. C.Y. Chen, W.L. Tsai, P.J. Lin, S.C. Shiesh, The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease. Clin. Chem. Lab. Med. 49, 1817–1821 (2011)

    Article  PubMed  CAS  Google Scholar 

  5. S.G. Ma, C.L. Wei, B. Hong, W.N. Yu, Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease. Clinics (Sao Paulo). 66, 1677–1680 (2011)

    Google Scholar 

  6. Y. Iwasaki, Y. Hamamoto, Y. Kawasaki, H. Ikeda, S. Honjo, Y. Wada, H. Koshiyama, Japanese cases of acute onset diabetic ketosis without acidosis in the absence of glutamic acid decarboxylase autoantibody. Endocrine 37, 286–288 (2010)

    Article  PubMed  CAS  Google Scholar 

  7. J. Wolfsdorf, M.E. Craig, D. Daneman, D. Dunger, J. Edge, W.R. Lee, A. Rosenbloom, M.A. Sperling, R. Hanas, International society for pediatric and adolescent diabetes. Diabetic ketoacidosis. Pediatr. Diabetes. 8, 28–43 (2007)

    Google Scholar 

  8. R.R. Dalton, W.H. Hoffman, G.G. Passmore, S.L. Martin, Plasma C-reactive protein levels in severe diabetic ketoacidosis. Ann. Clin. Lab. Sci. 33, 435–442 (2003)

    PubMed  CAS  Google Scholar 

  9. W.H. Hoffman, C.L. Burek, J.L. Waller, L.E. Fisher, M. Khichi, L.B. Mellick, Cytokine response to diabetic ketoacidosis and its treatment. Clin. Immunol. 108, 175–181 (2003)

    Article  PubMed  CAS  Google Scholar 

  10. C. Gabay, I. Kushner, Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448–454 (1999)

    Article  PubMed  CAS  Google Scholar 

  11. K. Ukinc, S. Eminagaoglu, H.O. Ersoz, C. Erem, C. Karahan, A.B. Hacihasanoglu, M. Kocak, A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine 36, 425–432 (2009)

    Article  PubMed  CAS  Google Scholar 

  12. A. Piwowar, M. Knapik-Kordecka, M. Warwas, Comparison of the usefulness of plasma levels of oxidatively modified forms of albumin in estimating kidney dysfunction in diabetic patients. Clin. Invest. Med. 33, E109 (2010)

    PubMed  CAS  Google Scholar 

  13. A. Turk, I. Nuhoglu, A. Mentese, S.C. Karahan, H. Erdol, C. Erem, The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde. Retina 31, 602–608 (2011)

    Article  PubMed  CAS  Google Scholar 

  14. W. Wei, Q. Liu, Y. Tan, L. Liu, X. Li, L. Cai, Oxidative stress, diabetes, and diabetic complications. Hemoglobin 33, 370–377 (2009)

    Article  PubMed  CAS  Google Scholar 

  15. M.C. Vantyghem, M. Balduyck, F. Zerimech, A. Martin, C. Douillard, S. Bans, P.M. Degand, J. Lefebvre, Oxidative markers in diabetic ketoacidosis. J. Endocrinol. Invest. 23, 732–736 (2000)

    PubMed  CAS  Google Scholar 

  16. F.B. Stentz, G.E. Umpierrez, R. Cuervo, A.E. Kitabchi, Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53, 2079–2086 (2004)

    Article  PubMed  CAS  Google Scholar 

  17. A. Piwowar, M. Knapik-Kordecka, M. Warwas, Ischemia-modified albumin level in type 2 diabetes mellitus—Preliminary report. Dis. Markers 24, 311–317 (2008)

    PubMed  CAS  Google Scholar 

  18. A.B. Erbagci, M. Tarakcioglu, Y. Coskun, E. Sivasli, E. Sibel Namiduru, Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children. Clin. Biochem. 34, 645–650 (2001)

    Article  PubMed  CAS  Google Scholar 

  19. A. Viardot, S.T. Grey, F. Mackay, D. Chisholm, Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 148, 346–353 (2007)

    Article  PubMed  CAS  Google Scholar 

  20. M. Firoozrai, M. Nourbakhsh, M. Razzaghy-Azar, Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes. Diabetes Res. Clin. Pract. 77, 427–432 (2007)

    Article  PubMed  CAS  Google Scholar 

  21. M. Krzystek-Korpacka, B. Salmonowicz, D. Boehm, I. Berdowska, B. Zielinski, E. Patryn, A. Noczynska, A. Gamian, Diagnostic potential of oxidative stress markers in children and adolescents with type 1 diabetes. Clin. Biochem. 41, 48–55 (2008)

    Article  PubMed  CAS  Google Scholar 

  22. Z. Rasheed, H.A. Al-Shobaili, A.A. Alzolibani, M. Ismail Khan, M. Tariq Ayub, M.I. Khan et al., Immunological functions of oxidized human immunoglobulin G in type 1 diabetes mellitus: its potential role in diabetic smokers as a biomarker of elevated oxidative stress. Dis. Markers 31, 47–54 (2011)

    PubMed  CAS  Google Scholar 

  23. A. Ceriello, K. Esposito, M. Ihnat, J. Thorpe, D. Giugliano, Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics. Diabet. Med. 27, 911–917 (2010)

    Article  PubMed  CAS  Google Scholar 

  24. A.E. Kitabchi, F.B. Stentz, G.E. Umpierrez, Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes. Biochem. Biophys. Res. Commun. 315, 404–407 (2004)

    Article  PubMed  CAS  Google Scholar 

  25. N.S. Glaser, S.L. Wootton-Gorges, M.H. Buonocore, J.P. Marcin, A. Rewers, J. Strain, J. DiCarlo, E.K. Neely, P. Barnes, N. Kuppermann, Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr. Diabetes 7, 75–80 (2006)

    Article  PubMed  Google Scholar 

  26. R. Hanas, F. Lindgren, B. Lindblad, Diabetic ketoacidosis and cerebral oedema in Sweden–a 2-year paediatric population study. Diabet. Med. 24, 1080–1085 (2007)

    Article  PubMed  CAS  Google Scholar 

  27. A.L. Rosenbloom, The management of diabetic ketoacidosis in children. Diabetes Ther. 1, 103–120 (2010)

    Article  PubMed  CAS  Google Scholar 

  28. X. Zhang, C. Chen, A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy. Endocrine. 2012 Feb 10. [Epub ahead of print]

  29. L. Weiss, S. Bernstein, R. Jones, R. Amunugama, D. Krizman, L. Jebailey, O. Almogi-Hazan, Z. Yekhtin, R. Shiner, I. Reibstein, E. Triche, S. Slavin, R. Or, E.R. Barnea, Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice. Endocrine 40, 41–54 (2011)

    Article  PubMed  CAS  Google Scholar 

  30. S. Sivanandan, A. Sinha, V. Jain, R. Lodha, Management of diabetic ketoacidosis. Indian J. Pediatr. 78, 576–584 (2011)

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no competing interests to declare.

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, The Affiliated Huai’an Hospital of Xuzhou Medical College, No. 62 South Huaihai Road, Huai’an, 223002, China

    Shao-gang Ma, Wei Xu, Wen Hu, Feng Bai & Xiao-juan Wu

  2. Department of Clinical Laboratory, The Affiliated Huai’an Hospital of Xuzhou Medical College, Huai’an, 223002, China

    Yue Jin

Authors
  1. Shao-gang Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yue Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wen Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Feng Bai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiao-juan Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shao-gang Ma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ma, Sg., Jin, Y., Xu, W. et al. Increased serum levels of ischemia-modified albumin and C-reactive protein in type 1 diabetes patients with ketoacidosis. Endocrine 42, 570–576 (2012). https://doi.org/10.1007/s12020-012-9652-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-012-9652-9

Keywords

Search

Navigation